UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization

Value in health, 2010-06, Vol.13 (4), p.381-387

2010

Volltextzugriff (PDF)

Is access to adjuvant treatments prioritized over therapies for metastatic cancer? The Israeli experience

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18599-e18599

2023

Volltextzugriff (PDF)

Hormone replacement therapy (HRT) and risk of distant recurrence in newly diagnosed ER+, node-negative (N-) breast-cancer (BC) patients: A retrospective population-based matched-cohort study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6591-6591

2019

Volltextzugriff (PDF)

Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3620-3620

2023

Volltextzugriff (PDF)

Publicly Funded Cancer Care: Are Adjuvant Therapies Prioritized Over Treatment of Metastatic Cancer? The Israeli Experience

JCO oncology practice, 2023-11

2023

Volltextzugriff (PDF)

Recurrence score (RS) differences between primary and second-primary breast cancer (BC): Exploratory analysis of the Clalit Health Services (CHS) registry

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e12587-e12587

2020

Volltextzugriff (PDF)

Screening and Diagnosis of Gestational Diabetes Mellitus: Critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level

Diabetes care, 2012-09, Vol.35 (9), p.1894-1896

2012

Volltextzugriff (PDF)

Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location

The oncologist (Dayton, Ohio), 2019-08, Vol.24 (8), p.e696-e701

2019

Volltextzugriff (PDF)

Abstract P1-10-16: Ethnicity, recurrence score (RS) distribution, and clinical outcomes in ER+ HER2-negative breast cancer (BC) patients (pts) in Israel

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-10-16

2020

Volltextzugriff (PDF)

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

NPJ breast cancer, 2017-09, Vol.3 (1), p.32-7, Article 32

2017

Volltextzugriff (PDF)

Sidedness matters: Surrogate biomarkers prognosticate colorectal cancer upon anatomic location

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.523-523

2017

Volltextzugriff (PDF)

Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis

The breast journal, 2020-10, Vol.26 (10), p.2096-2098

2020

Volltextzugriff (PDF)

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

NPJ breast cancer, 2017-09, Vol.3 (1), p.33-8, Article 33

2017

Volltextzugriff (PDF)

Oncotype-DX recurrence score distribution among breast cancer patients harboring a germline mutation in the BRCA1/2 genes

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.564-564

2015

Volltextzugriff (PDF)

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

NPJ breast cancer, 2019-11, Vol.5 (1), p.1-6, Article 41

2019

Volltextzugriff (PDF)

Treatments/clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions were recurrence score (RS)-guided: Analysis by histologic subtype

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12053-e12053

2017

Volltextzugriff (PDF)

Clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions incorporated the 21-gene recurrence score (RS): Elderly (≥70 yrs) vs younger patients (Pts)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.543-543

2017

Volltextzugriff (PDF)

Screening and Diagnosis of Gestational Diabetes Mellitus

Diabetes care, 2012-09, Vol.35 (9), p.1894-1896

2012

Volltextzugriff (PDF)

Screening and diagnosis of gestational diabetes mellitus: critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level

Diabetes care, 2012-09, Vol.35 (9), p.1894-1896

2012

Volltextzugriff (PDF)

Association of the colon cancer recurrence score with treatments received in patients with stage II colon cancer: The Clalit Health Services experience

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e22111-e22111

2013

Volltextzugriff (PDF)

Adherence by primary care physicians to guidelines for the clinical management of dyslipidemia

The Israel Medical Association journal, 2011-11, Vol.13 (11), p.657-662

2011

Volltextzugriff (PDF)

Identification of K-RAS mutations in colorectal cancer patients in Israel

הרפואה, 2011-05, Vol.150 (5), p.447

2011

Volltextzugriff (PDF)

'Diabetes in the community': a nationwide diabetes improvement programme in primary care in Israel

Quality in primary care, 2005-01, Vol.13 (2)

2005

Volltextzugriff (PDF)

Hopeless Necromantics: Decomposition and Transcorporeal Love in Jim Crace’s Being Dead

Nonhuman Agencies in the Twenty-First-Century Anglophone Novel, p.147-166

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization

Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients

Is access to adjuvant treatments prioritized over therapies for metastatic cancer? The Israeli experience

Hormone replacement therapy (HRT) and risk of distant recurrence in newly diagnosed ER+, node-negative (N-) breast-cancer (BC) patients: A retrospective population-based matched-cohort study

Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data

Publicly Funded Cancer Care: Are Adjuvant Therapies Prioritized Over Treatment of Metastatic Cancer? The Israeli Experience

Recurrence score (RS) differences between primary and second-primary breast cancer (BC): Exploratory analysis of the Clalit Health Services (CHS) registry

Screening and Diagnosis of Gestational Diabetes Mellitus: Critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level

Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location

Abstract P1-10-16: Ethnicity, recurrence score (RS) distribution, and clinical outcomes in ER+ HER2-negative breast cancer (BC) patients (pts) in Israel

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

Sidedness matters: Surrogate biomarkers prognosticate colorectal cancer upon anatomic location

Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

Oncotype-DX recurrence score distribution among breast cancer patients harboring a germline mutation in the BRCA1/2 genes

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

Treatments/clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions were recurrence score (RS)-guided: Analysis by histologic subtype

Clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions incorporated the 21-gene recurrence score (RS): Elderly (≥70 yrs) vs younger patients (Pts)

Screening and Diagnosis of Gestational Diabetes Mellitus

Screening and diagnosis of gestational diabetes mellitus: critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level

Association of the colon cancer recurrence score with treatments received in patients with stage II colon cancer: The Clalit Health Services experience

Adherence by primary care physicians to guidelines for the clinical management of dyslipidemia

Identification of K-RAS mutations in colorectal cancer patients in Israel

'Diabetes in the community': a nationwide diabetes improvement programme in primary care in Israel

Hopeless Necromantics: Decomposition and Transcorporeal Love in Jim Crace’s Being Dead

Suchergebnisse filtern